Skip to main content

Memantine News

Forest and Merz Announce FDA Approval of Namenda XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type

NEW YORK--(BUSINESS WIRE)--Jun 21, 2010 - Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that Namenda XR (memantine hydrochloride) was approved by the U.S. Food and Drug...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Alzheimer's Disease, Autism, Migraine

Memantine patient information at Drugs.com